Errol Spence had eye surgery on Wednesday

Just two days after learning of his torn retina, Unified World Welterweight Champion Errol Spence has had surgery in the past.

Spence, who had to withdraw from his title defense on August 21 against the future Hall of Famer Manny Pacquiao, posted a photo to Instagram on Wednesday showing the heavily bandaged left eye, which was first discovered to have a tear in the retina during the Nevada Athletic Commission physical exam on Monday.


Spence said on social media Tuesday that he had obtained several opinions, including two in his home state of Texas, on the injury,

Spence, 31, 27-0, 21 KOs, was last in action in December on a PBC / Fox Sports pay-per-view, when he decided Danny Garcia (pictured above) at AT&T Stadium to keep both titles. It was his return to the ring after a horrific car crash in October 2019, where he was thrown from his vehicle but escaped serious injury or death.

Spence had been out of action for 14 months after beating Shawn Porter for his WBC belt in Los Angeles in September 2019. His physiotherapy and rehabilitation, as well as the Covid 19 pandemic delayed things until December to come back on the ring with Garcia.

Spence and Pacquiao should have met in the biggest non-heavyweight fight of 2021 at T-Mobile Arena, on PPV a week from Saturday. This was before the damaged eye was discovered in Nevada and it should take at least three months for his eye to heal completely.

So now future Hall of Famer Pacquiao, 62-7-2, will instead fight the WBA World Champion, Yordenis Ugas. Ugas, 35, is 26-4 and preparing to defend his first title against Fabian Maidana in the Spence-Pacquiao PPV card co-feature.

He’s a former Cuban amateur star, who won bronze at the 2008 Olympics, and he won a split decision over Abel Ramos in Los Angeles in September 2020. The WBA called this fight, as for the version “regular” in their 147 lb Championship. However, they have since named him as their “world champion”, due to Pacquiao’s two years of inactivity.

Source link

Comments are closed.